EP3551629
Oxabísýklóheptan til stillingar á ónæmissvörun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.12.2017EP published:
15.11.2023EP application number:
17879038.2
EP translation filed:
5.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
7.12.2037Expiry date:
7.12.2026Next due date:
31.12.2026
Title in English:
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSELanguage of the patent:
English
Timeline
Today
8.12.2017EP application
15.11.2023EP Publication
5.2.2024Translation submitted
15.3.2024Registration published
7.12.2026Expires
Owner
Name:
Lixte Biotechnology, Inc.Address:
680 E. Colorado Blvd., Suite 180, Pasadena, CA 91101, US
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health, 6701 Rockledge Drive, Suite 700, Bethesda, MD 20892, US
Inventor
Name:
KOVACH, John S.Address:
East Setauket, New York 11733, US
Name:
ZHUANG, ZhengpingAddress:
Bethesda, Maryland 20814, US
Name:
HO, Sze Chun WinsonAddress:
6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, Maryland 20892-7660, US
Name:
WANG, HeruiAddress:
6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, Maryland 20892-7660, US
Name:
LU, RongzeAddress:
Sunnyvale, CA 94085, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662497949 PDate:
8.12.2016Country:
US
Number:
201762465001 PDate:
28.2.2017Country:
US
Number:
201762545373 PDate:
14.8.2017Country:
US
Classification
Categories:
C07D 471/04, C07D 405/14, A61K 31/4439, A61K 9/00, A61K 31/4525, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 31.1.2024
Expires: 7.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.12.2024
Expires: 7.12.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 11.12.2025
Expires: 7.12.2026
Payer: G.H. Sigurgeirsson ehf.